Subthreshold Concentrations of Melatonin and Galantamine Improves Pathological AD-Hallmarks in Hippocampal Organotypic Cultures
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Subthreshold Concentrations of Melatonin and Galantamine Improves Pathological AD-Hallmarks in Hippocampal Organotypic Cultures
Authors
Keywords
Alzheimer disease, Melatonin, Galantamine, Combined therapy, Inflammation, Oxidative stress
Journal
MOLECULAR NEUROBIOLOGY
Volume 53, Issue 5, Pages 3338-3348
Publisher
Springer Nature
Online
2015-06-16
DOI
10.1007/s12035-015-9272-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Retrospective Study on the Benefits of Combined Memantine and cholinEsterase inhibitor treatMent in AGEd Patients affected with Alzheimer's Disease: The MEMAGE Study
- (2018) Pietro Gareri et al. JOURNAL OF ALZHEIMERS DISEASE
- Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer's Disease: A Systematic Review and Meta-Analysis
- (2018) Chen-Chen Tan et al. JOURNAL OF ALZHEIMERS DISEASE
- The Melatonin–N,N-Dibenzyl(N-methyl)amine Hybrid ITH91/IQM157 Affords Neuroprotection in an in Vitro Alzheimer’s Model via Hemo-oxygenase-1 Induction
- (2014) Izaskun Buendia et al. ACS Chemical Neuroscience
- Oxidative damage and the Nrf2-ARE pathway in neurodegenerative diseases
- (2014) Li Gan et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Proliferation in the Alzheimer Hippocampus Is due to Microglia, Not Astroglia, and Occurs at Sites of Amyloid Deposition
- (2014) Michael W. Marlatt et al. NEURAL PLASTICITY
- Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer’s disease: a 6-month, randomized, placebo-controlled, multicenter trial
- (2014) Moshe Laudon et al. Clinical Interventions in Aging
- Alkaloids as a source of potential anticholinesterase inhibitors for the treatment of Alzheimer's disease
- (2013) Eduardo Luis Konrath et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Reciprocal interactions between sleep, circadian rhythms and Alzheimer's disease: Focus on the role of hypocretin and melatonin
- (2012) Diane Slats et al. AGEING RESEARCH REVIEWS
- Melatonin-mitochondria Interplay in Health and Disease
- (2012) Dario Acuna Castroviejo et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- The role of melatonin in acute myocardial infarction
- (2012) Alberto Dominguez-Rodriguez Frontiers in Bioscience-Landmark
- On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK
- (2012) Annia Galano et al. JOURNAL OF PINEAL RESEARCH
- Antioxidant Therapies for Alzheimer's Disease
- (2012) Ye Feng et al. Oxidative Medicine and Cellular Longevity
- Melatonin as a natural ally against oxidative stress: a physicochemical examination
- (2011) Annia Galano et al. JOURNAL OF PINEAL RESEARCH
- Alzheimer’s disease: pathological mechanisms and the beneficial role of melatonin
- (2011) Sergio A. Rosales-Corral et al. JOURNAL OF PINEAL RESEARCH
- Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease
- (2011) Rafael León et al. MEDICINAL RESEARCH REVIEWS
- Galantamine elicits neuroprotection by inhibiting iNOS, NADPH oxidase and ROS in hippocampal slices stressed with anoxia/reoxygenation
- (2011) J. Egea et al. NEUROPHARMACOLOGY
- Amyloid-β neurotoxicity in organotypic culture is attenuated by melatonin: involvement of GSK-3β,tauand neuroinflammation
- (2010) Juliana Bender Hoppe et al. JOURNAL OF PINEAL RESEARCH
- Melatonin ameliorates Alzheimer-like pathological changes and spatial memory retention impairment induced by calyculin A
- (2010) Xifei Yang et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Melatonin: Signaling mechanisms of a pleiotropic agent
- (2009) Rüdiger Hardeland BIOFACTORS
- Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin
- (2009) Russel J. Reiter et al. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease
- (2009) James M. Olcese et al. JOURNAL OF PINEAL RESEARCH
- Amyloid- and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice
- (2009) V. Rhein et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Comparative Study of β-Amyloid Peptides Aβ1-42 and Aβ25-35 Toxicity in Organotypic Hippocampal Slice Cultures
- (2008) Rudimar Luiz Frozza et al. NEUROCHEMICAL RESEARCH
- Galantamine reduces striatal degeneration in 3-nitropropionic acid model of Huntington's disease
- (2008) Jung-Eun Park et al. NEUROSCIENCE LETTERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search